Highlights

SLUSH retournee OASYS NOW, continues to make strides in patient-centric innovation. Since its product launch of GRIP at SLUSH 2023, the company has been expanding its Clinical Trial Matchmaking platform, helping patients with chronic and rare diseases connect with relevant clinical trials globally. This year, OASYS NOW took home the SLUSH 100 Competition grand prize of €1 million, further accelerating its mission to revolutionise patient recruitment for clinical trials.

On 1 December, OASYS NOW, a Delft-based Healthtech startup specializing in clinical data, will officially launch its Clinical Trial Matchmaking platform European-wide at the SLUSH conference in Helsinki. OASYS NOW has developed a recommender algorithm that creates insights from health data, using advanced cryptographic techniques and AI, to match patients' data with all possible clinical trial options, worldwide. This platform empowers patients with chronic and rare (genetic) diseases to find and get access to clinical trials, and helps Life Science organizations gain valuable insights from large health data.

SLUSH attendee HULO.ai, a startup that develops advanced AI algorithms to tackle water loss, has secured €800K in a fresh round of funding from LUMO Labs and the Netherlands Enabling Water Technology (NEW) Fund.

Circularise, a blockchain platform for supply chain transparency, has successfully closed a SAFE with SEKISUI CHEMICAL, a leading plastics manufacturer. SEKISUI's investment extends beyond financial support, encompassing a joint project in chemicals traceability. The collaboration involves introducing a digital product passport and testing mass balance traceability software in SEKISUI's supply chain. This SAFE follows Circularise's Series A funding in 2022 and is a crucial milestone, with SEKISUI joining other notable investors. The investment not only injects capital but sets the stage for a Series B funding round, supporting Circularise's expansion in the chemicals market amid evolving sustainability regulations.